CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)
$31.32 -0.01 (-0.0319%)
Analysed CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) News Sources
This Biotech Stock Has Soared 175%. Here’s Why One Fund Still Sold $3 Million Worth
09-05-2026
fool.com
Catalyst Pharmaceuticals Buyout And FIRDAPSE Patents Reframe Investor Outlook
10-05-2026
yahoo.com
Angelini Pharma agrees $4.1bn Catalyst Pharmaceuticals acquisition
11-05-2026
investmentmonitor.ai
Catalyst Pharmaceuticals Reports First Quarter 2026 Financial Results
11-05-2026
yahoo.com
Catalyst Pharmaceutical (CPRX) Surpasses Q1 Earnings and Revenue Estimates
11-05-2026
yahoo.com
Catalyst (CPRX) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
11-05-2026
yahoo.com
Catalyst Pharmaceuticals Q1 Earnings Beat, Firdapse Revenues Rise Y/Y
12-05-2026
yahoo.com
CPRX or UTHR: Which Is the Better Value Stock Right Now?
14-05-2026
yahoo.com
Angelini Buyout And FIRDAPSE Settlement Reframe Catalyst Pharmaceuticals Story
20-05-2026
yahoo.com
GlobeFlex Exits NCR Atleos After Brink’s Buyout Deal
20-05-2026
fool.com
What is the current price of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The current price of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is $31.32.
CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) absolute price change since previous trading day?
The absolute price change of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) since the previous trading day is $-0.01.
CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) percentage price change since previous trading day?
The percentage price change of CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) since the previous trading day is -0.0319%.
What is the most recent average sentiment score for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The most recent average sentiment score for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is 81 out of 100.
What is the most recent average sentiment for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)?
The most recent sentiment for CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ) is .
SEC-8K** Filing Available For CATALYST PHARMACEUTICALS INC (CPRX:NASDAQ)
** material developments that could impact a company's financial condition or stock price.
Author: MattELab
MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.